Clinical studies have demonstrated its effectiveness in obesity treatment, showing significant reductions in body weight, BMI, waist and hip circumference, and body fat, outperforming placebos and setting new standards for weight loss therapies
BPC-157 is classified as a prohibited substance in competitive sport by multiple professional and collegiate sports organisations
Individuals who have gotten these resources are going to continue to utilize these products. After the meeting, the FDA will review the votes, discussion and public comments before making a decision on each of the peptides
Compounding pharmacies make customized medicines for individual patients, and under section 503A of the Food, Drug, and Cosmetic Act, a pharmacy can compound from a bulk substance only if that substance has an official quality monograph, is a component of an FDA-approved drug, or has been formally added to an approved bulks list. BPC-157 qualifies on none of those counts, which is why the FDA placed it in Category 2 of its 503A bulk-substance review in September of 2023
Specifically, its inflammation in the subtalar joint where your ankle bone (talus) meets your heel bone (calcaneus)
